| Anjali Shetty, | |
|
33920 Us 19 N Ste 241, Palm Harbor, FL 34684-2672 | |
| (727) 773-9793 | |
| (727) 773-0674 |
| Full Name | Anjali Shetty |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 14 Years |
| Location | 33920 Us 19 N Ste 241, Palm Harbor, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720303555 | NPI | - | NPPES |
| 593548577 | Other | FL | TAXPAYER IDENTIFICATION NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | ME121856 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| St Josephs Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arthritis Associates Of Florida, Pa | 1557340973 | 5 |
News Archive
Amgen and Xencor, announced today that they will collaborate to develop XmAb®5871, an Fc- engineered monoclonal antibody dually targeting CD19 and CD32b. XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases.
The Washington Post: "House Speaker Nancy Pelosi (D-Calif.) and her leadership team won a hard-fought victory on Obama's most critical domestic policy agenda item by neutralizing the most potentially toxic political issue well in advance of the final vote, siding with centrists on their preferred version of the public option. She then publicly dared the progressive wing, with its strong commitment to establishing national health insurance, to take down the entire package because one piece was not to their liking."
Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.
Dauntless Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of specialty drugs and Aegis Therapeutics, LLC today announced a licensing agreement providing Dauntless' access to Aegis' Intravail drug delivery technology for an undisclosed oncology application and an option for three additional drugs.
A group of 25 hospitals across 7 hospital systems in New York, New Jersey and Pennsylvania will form what it calls the nation's largest health care alliance to improve care and lower costs.
› Verified 3 days ago
| Entity Name | Arthritis Associates Of Florida, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821285156 PECOS PAC ID: 1557340973 Enrollment ID: O20040719000354 |
News Archive
Amgen and Xencor, announced today that they will collaborate to develop XmAb®5871, an Fc- engineered monoclonal antibody dually targeting CD19 and CD32b. XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases.
The Washington Post: "House Speaker Nancy Pelosi (D-Calif.) and her leadership team won a hard-fought victory on Obama's most critical domestic policy agenda item by neutralizing the most potentially toxic political issue well in advance of the final vote, siding with centrists on their preferred version of the public option. She then publicly dared the progressive wing, with its strong commitment to establishing national health insurance, to take down the entire package because one piece was not to their liking."
Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.
Dauntless Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of specialty drugs and Aegis Therapeutics, LLC today announced a licensing agreement providing Dauntless' access to Aegis' Intravail drug delivery technology for an undisclosed oncology application and an option for three additional drugs.
A group of 25 hospitals across 7 hospital systems in New York, New Jersey and Pennsylvania will form what it calls the nation's largest health care alliance to improve care and lower costs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anjali Shetty, 33920 Us 19 N Ste 241, Palm Harbor, FL 34684-2672 Ph: (727) 773-9793 | Anjali Shetty, 33920 Us 19 N Ste 241, Palm Harbor, FL 34684-2672 Ph: (727) 773-9793 |
News Archive
Amgen and Xencor, announced today that they will collaborate to develop XmAb®5871, an Fc- engineered monoclonal antibody dually targeting CD19 and CD32b. XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases.
The Washington Post: "House Speaker Nancy Pelosi (D-Calif.) and her leadership team won a hard-fought victory on Obama's most critical domestic policy agenda item by neutralizing the most potentially toxic political issue well in advance of the final vote, siding with centrists on their preferred version of the public option. She then publicly dared the progressive wing, with its strong commitment to establishing national health insurance, to take down the entire package because one piece was not to their liking."
Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.
Dauntless Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of specialty drugs and Aegis Therapeutics, LLC today announced a licensing agreement providing Dauntless' access to Aegis' Intravail drug delivery technology for an undisclosed oncology application and an option for three additional drugs.
A group of 25 hospitals across 7 hospital systems in New York, New Jersey and Pennsylvania will form what it calls the nation's largest health care alliance to improve care and lower costs.
› Verified 3 days ago
Dr. Tatiana P. Nagibina, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 32615 Us Highway 19 N, Suite 2, Palm Harbor, FL 34684 Phone: 727-789-2784 Fax: 727-785-3537 | |
Dr. James Patrick Fischer, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 34637 Us Highway 19 N, Palm Harbor, FL 34684 Phone: 727-786-1673 Fax: 727-785-0284 | |
Dr. Linda L. Diedriech, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4705 Alt 19 Ste B, Palm Harbor, FL 34683 Phone: 727-935-6477 Fax: 727-935-6478 | |
Milan Ravindra Patel, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 33920 Us 19 N Ste 124, Palm Harbor, FL 34684 Phone: 727-785-7654 Fax: 727-787-0061 | |
Kurt N Harris, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 3820 Tampa Rd, #202, Palm Harbor, FL 34684 Phone: 727-785-4540 Fax: 727-784-9724 | |
Lilia Rene Stefaniwsky, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 33920 Us 19 N Ste 124, Palm Harbor, FL 34684 Phone: 727-785-7654 Fax: 727-787-0061 | |
Edward Mcaloon, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 108 Homeport Dr, Palm Harbor, FL 34683 Phone: 727-744-5751 |